CHEBI:50427 - platelet aggregation inhibitor

ChEBI IDCHEBI:50427
ChEBI Nameplatelet aggregation inhibitor
Stars
DefinitionA drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Last Modified2 July 2025
SubmitterInma Spiteri
ChEBI Ontology
Outgoing Relation(s)
platelet aggregation inhibitor (CHEBI:50427) is a hematologic agent (CHEBI:50248)
Incoming Relation(s)
(±)-suloctidil (CHEBI:233445) has role platelet aggregation inhibitor (CHEBI:50427)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (CHEBI:140850) has role platelet aggregation inhibitor (CHEBI:50427)
(E)-3-tosylacrylonitrile (CHEBI:85928) has role platelet aggregation inhibitor (CHEBI:50427)
(S)-glaucine (CHEBI:5373) has role platelet aggregation inhibitor (CHEBI:50427)
N-tert-butyl(3,5,6-trimethylpyrazin-2-yl)methanimine N-oxide (CHEBI:133247) has role platelet aggregation inhibitor (CHEBI:50427)
N-trans-cinnamoyltyramine (CHEBI:177872) has role platelet aggregation inhibitor (CHEBI:50427)
S-nitroso-L-cysteine (CHEBI:138935) has role platelet aggregation inhibitor (CHEBI:50427)
S-nitrosoglutathione (CHEBI:50091) has role platelet aggregation inhibitor (CHEBI:50427)
cis-ferulic acid (CHEBI:76117) has role platelet aggregation inhibitor (CHEBI:50427)
12-HPEPE (CHEBI:78909) has role platelet aggregation inhibitor (CHEBI:50427)
12-HPEPE(1−) (CHEBI:78078) has role platelet aggregation inhibitor (CHEBI:50427)
2-acetamidophenol (CHEBI:143107) has role platelet aggregation inhibitor (CHEBI:50427)
4-phenyl-3-furoxancarbonitrile (CHEBI:180495) has role platelet aggregation inhibitor (CHEBI:50427)
4,4'-dihydroxybenzyl sulfone (CHEBI:65786) has role platelet aggregation inhibitor (CHEBI:50427)
6-oxoprostaglandin E1 (CHEBI:28269) has role platelet aggregation inhibitor (CHEBI:50427)
acadesine (CHEBI:28498) has role platelet aggregation inhibitor (CHEBI:50427)
acetylsalicylic acid (CHEBI:15365) has role platelet aggregation inhibitor (CHEBI:50427)
ACT-333679 (CHEBI:90848) has role platelet aggregation inhibitor (CHEBI:50427)
actinodaphnine (CHEBI:2444) has role platelet aggregation inhibitor (CHEBI:50427)
aglafolin (CHEBI:65374) has role platelet aggregation inhibitor (CHEBI:50427)
anagrelide (CHEBI:142290) has role platelet aggregation inhibitor (CHEBI:50427)
anagrelide hydrochloride (CHEBI:55345) has role platelet aggregation inhibitor (CHEBI:50427)
angelitriol (CHEBI:132402) has role platelet aggregation inhibitor (CHEBI:50427)
angelol-J (CHEBI:132768) has role platelet aggregation inhibitor (CHEBI:50427)
asperenone (CHEBI:133813) has role platelet aggregation inhibitor (CHEBI:50427)
AT-1015 hydrochloride (CHEBI:228366) has role platelet aggregation inhibitor (CHEBI:50427)
AT-1015 hydrochloride monohydrate (CHEBI:234343) has role platelet aggregation inhibitor (CHEBI:50427)
azelastine (CHEBI:2950) has role platelet aggregation inhibitor (CHEBI:50427)
azelastine hydrochloride (CHEBI:2951) has role platelet aggregation inhibitor (CHEBI:50427)
bassiatin (CHEBI:65465) has role platelet aggregation inhibitor (CHEBI:50427)
BAY 41-2272 (CHEBI:142435) has role platelet aggregation inhibitor (CHEBI:50427)
benzo[d]isothiazol-3-one (CHEBI:167099) has role platelet aggregation inhibitor (CHEBI:50427)
beraprost (CHEBI:135633) has role platelet aggregation inhibitor (CHEBI:50427)
beraprost sodium (CHEBI:31270) has role platelet aggregation inhibitor (CHEBI:50427)
bianfugenine (CHEBI:132719) has role platelet aggregation inhibitor (CHEBI:50427)
bis-(4-hydroxybenzyl)ether (CHEBI:65501) has role platelet aggregation inhibitor (CHEBI:50427)
cangrelor (CHEBI:90841) has role platelet aggregation inhibitor (CHEBI:50427)
cangrelor tetrasodium (CHEBI:90836) has role platelet aggregation inhibitor (CHEBI:50427)
carmoxirole (CHEBI:64200) has role platelet aggregation inhibitor (CHEBI:50427)
carmoxirole hydrochloride (CHEBI:64199) has role platelet aggregation inhibitor (CHEBI:50427)
cilostazol (CHEBI:31401) has role platelet aggregation inhibitor (CHEBI:50427)
clonixin (CHEBI:76200) has role platelet aggregation inhibitor (CHEBI:50427)
clonixin lysine salt (CHEBI:76201) has role platelet aggregation inhibitor (CHEBI:50427)
clopidogrel (CHEBI:37941) has role platelet aggregation inhibitor (CHEBI:50427)
clopidogrel sulfate (CHEBI:3759) has role platelet aggregation inhibitor (CHEBI:50427)
cyclomorusin A (CHEBI:132868) has role platelet aggregation inhibitor (CHEBI:50427)
cytochalasin B (CHEBI:23527) has role platelet aggregation inhibitor (CHEBI:50427)
diallyl trisulfide (CHEBI:78492) has role platelet aggregation inhibitor (CHEBI:50427)
dilazep (CHEBI:92842) has role platelet aggregation inhibitor (CHEBI:50427)
dilazep dihydrochloride (CHEBI:31493) has role platelet aggregation inhibitor (CHEBI:50427)
dipyridamole (CHEBI:4653) has role platelet aggregation inhibitor (CHEBI:50427)
dithiadene (CHEBI:167625) has role platelet aggregation inhibitor (CHEBI:50427)
droxicam (CHEBI:76133) has role platelet aggregation inhibitor (CHEBI:50427)
edoxaban (CHEBI:85973) has role platelet aggregation inhibitor (CHEBI:50427)
edoxaban tosylate (CHEBI:85975) has role platelet aggregation inhibitor (CHEBI:50427)
edoxaban tosylate hydrate (CHEBI:85974) has role platelet aggregation inhibitor (CHEBI:50427)
EET (CHEBI:64007) has role platelet aggregation inhibitor (CHEBI:50427)
eptifibatide (CHEBI:291902) has role platelet aggregation inhibitor (CHEBI:50427)
forskolin (CHEBI:42471) has role platelet aggregation inhibitor (CHEBI:50427)
galgravin (CHEBI:132648) has role platelet aggregation inhibitor (CHEBI:50427)
herquline A (CHEBI:229724) has role platelet aggregation inhibitor (CHEBI:50427)
herquline B (CHEBI:66012) has role platelet aggregation inhibitor (CHEBI:50427)
hydroxysafflor yellow A (CHEBI:139030) has role platelet aggregation inhibitor (CHEBI:50427)
iloprost (CHEBI:63916) has role platelet aggregation inhibitor (CHEBI:50427)
isobavachalcone (CHEBI:28106) has role platelet aggregation inhibitor (CHEBI:50427)
isotanshinone IIB (CHEBI:66098) has role platelet aggregation inhibitor (CHEBI:50427)
LFM-A13 (CHEBI:183517) has role platelet aggregation inhibitor (CHEBI:50427)
lificiguat (CHEBI:142430) has role platelet aggregation inhibitor (CHEBI:50427)
methyl brevifolincarboxylate (CHEBI:66711) has role platelet aggregation inhibitor (CHEBI:50427)
milrinone (CHEBI:50693) has role platelet aggregation inhibitor (CHEBI:50427)
milrinone lactate (CHEBI:34850) has role platelet aggregation inhibitor (CHEBI:50427)
miroprofen (CHEBI:76249) has role platelet aggregation inhibitor (CHEBI:50427)
ML355 (CHEBI:195557) has role platelet aggregation inhibitor (CHEBI:50427)
neobavaisoflavone (CHEBI:66614) has role platelet aggregation inhibitor (CHEBI:50427)
nisoldipine (CHEBI:7577) has role platelet aggregation inhibitor (CHEBI:50427)
oleoyl danshenxinkun A (CHEBI:66819) has role platelet aggregation inhibitor (CHEBI:50427)
oleoyl neocryptotanshinone (CHEBI:66820) has role platelet aggregation inhibitor (CHEBI:50427)
procainamide (CHEBI:8428) has role platelet aggregation inhibitor (CHEBI:50427)
prostaglandin E1 (CHEBI:15544) has role platelet aggregation inhibitor (CHEBI:50427)
resolvin D5 (CHEBI:138645) has role platelet aggregation inhibitor (CHEBI:50427)
sapinmusaponin Q (CHEBI:66169) has role platelet aggregation inhibitor (CHEBI:50427)
sapinmusaponin R (CHEBI:66170) has role platelet aggregation inhibitor (CHEBI:50427)
sciadopitysin (CHEBI:9050) has role platelet aggregation inhibitor (CHEBI:50427)
selexipag (CHEBI:90844) has role platelet aggregation inhibitor (CHEBI:50427)
sevoflurane (CHEBI:9130) has role platelet aggregation inhibitor (CHEBI:50427)
SKF-96365 hydrochloride (CHEBI:145121) has role platelet aggregation inhibitor (CHEBI:50427)
sophoraflavanone B (CHEBI:50207) has role platelet aggregation inhibitor (CHEBI:50427)
splitomicin (CHEBI:75272) has role platelet aggregation inhibitor (CHEBI:50427)
surfactin (CHEBI:29681) has role platelet aggregation inhibitor (CHEBI:50427)
surfactin C (CHEBI:71978) has role platelet aggregation inhibitor (CHEBI:50427)
syringetin (CHEBI:18215) has role platelet aggregation inhibitor (CHEBI:50427)
taiwanin C (CHEBI:191411) has role platelet aggregation inhibitor (CHEBI:50427)
tetramethylpyrazine (CHEBI:133246) has role platelet aggregation inhibitor (CHEBI:50427)
ticagrelor (CHEBI:68558) has role platelet aggregation inhibitor (CHEBI:50427)
ticlopidine (CHEBI:9588) has role platelet aggregation inhibitor (CHEBI:50427)
treprostinil (CHEBI:50861) has role platelet aggregation inhibitor (CHEBI:50427)
troglitazone (CHEBI:9753) has role platelet aggregation inhibitor (CHEBI:50427)
VAS2870 (CHEBI:233997) has role platelet aggregation inhibitor (CHEBI:50427)
vinigrol (CHEBI:222218) has role platelet aggregation inhibitor (CHEBI:50427)
vitexin (CHEBI:16954) has role platelet aggregation inhibitor (CHEBI:50427)
vorapaxar (CHEBI:82702) has role platelet aggregation inhibitor (CHEBI:50427)
vorapaxar sulfate (CHEBI:83314) has role platelet aggregation inhibitor (CHEBI:50427)
xenocyloin (CHEBI:156365) has role platelet aggregation inhibitor (CHEBI:50427)
yinyanghuo A (CHEBI:66492) has role platelet aggregation inhibitor (CHEBI:50427)
yinyanghuo B (CHEBI:66493) has role platelet aggregation inhibitor (CHEBI:50427)
β-benzoyloxypaeoniflorin (CHEBI:132791) has role platelet aggregation inhibitor (CHEBI:50427)
δ-guaiene (CHEBI:63447) has role platelet aggregation inhibitor (CHEBI:50427)
partial prostacyclin agonist (CHEBI:51577) is a platelet aggregation inhibitor (CHEBI:50427)
platelet glycoprotein-IIb/IIIa receptor antagonist (CHEBI:50433) is a platelet aggregation inhibitor (CHEBI:50427)
Synonym  Source
platelet aggregation inhibitorsChEBI